The premium amount will be paid by the state government for...
Category:
Health
Latest
Pharma cos with over Rs 250 cr turnover have to adopt good manufacturing practices within 6 months: Mandaviya
Recently, drug regulators inspected 162 units and 14 public testing...
GSK sues Pfizer in US for patent infringement over RSV vaccine
British biopharmaceutical giant GSK sued Pfizer in Delaware federal...
COVID-19: MHA issues new guidelines, asks states/UTs to follow ‘Test-Track-Treat’ protocol
While talking about vaccination, the MHA said: “While the vaccination drive is proceeding smoothly, the pace is uneven across different states and UTs; and, the slow pace of vaccination in some states/ UTs is a matter of concern. Vaccination against COVID-19, in the present scenario, is critical to break the chain of transmission.”
Suspension of international passenger flights extended till April 30
“However, international scheduled flights may be allowed on selected routes by the competent authority on a case-to-case basis,” the DGCA added.
89 deaths reported following COVID vaccination till March 16, but none attributed to vaccine: Govt
Adequate measures have been put in place to manage AEFI cases like availability of anaphylaxis kits at each vaccination site, immediate referral to adverse events following immunization (AEFI) management centre and observation of vaccine recipients for 30 minutes at session site so as to take timely corrective measure.
Notify health policy for rare diseases by March 31, HC asks Centre; directs setting up of R&D body
It also asked the government to consider increasing the budget for rare diseases for the upcoming financial year 2021-22 and said the policy should deal with giving financial incentives for manufacturing drugs and contributing towards treatment of rare diseases.
AstraZeneca says US trial data shows vaccine 79% effective
While the AstraZeneca vaccine has been authorized in more than 50 countries worldwide, scientists have been awaiting results of the U.S. study in hopes it will clear up some of the confusion about just how well the shots really work
Asia accelerates AstraZeneca Covid-19 vaccine rollouts, even as trust plunges in Europe
The AstraZeneca shot was among the first and cheapest of the Covid-19 vaccines to be developed and launched at volume and is set to be the mainstay of vaccination programmes in much of the developing world.
But its brief suspension raised concerns that a slowdown in vaccination rollouts could hurt the global fight against the pandemic, as coronavirus cases surge in some countries, overwhelming healthcare systems and hurting economies.
India records highest single-day surge since mid November
New Delhi: India added 90,797 cases of coronavirus in two days with 46,951 new infections being recorded in a span of 24 hours, the highest so far this year, taking the nationwide COVID-19 tally to 1,16,46,081, according to the Union Health Ministry...
A year after ‘Janata curfew’, coronavirus threat rears its ugly head again
India stands at number one position in terms of recovered coronavirus cases followed by Brazil, while it is in the third spot in terms of the cases after the US and Brazil, according to the Johns Hopkins University, which has been compiling global COVID-19 data.
India to increase interval between doses of AstraZeneca shot
NEW DELHI: India’s health ministry on Monday wrote to states asking them to administer second AstraZeneca coronavirus vaccine doses,Covishield, to recipients within four to eight weeks, from the current guideline of four to six weeks. “The...
Hyderabad-based Virchow Biotech to produce up to 200 mn doses of Sputnik V
The announcement follows similar deals with Indian pharmaceutical firms Gland Pharma, Stelis Biopharma and Hetero.
“Virchow’s proven capabilities in large-scale drug substance manufacturing should help meet the global demand for this vaccine,” Dr. Tummuru Murali, Managing Director of Virchow Biotech, said in a statement issued by RDIF.